In a large-scale multi-omics analysis, elevated expression of PKCα protein was associated with poor prognosis in patients with bladder cancer, in addition to increased expression of beclin, epidermal growth factor receptor (EGFR), annexin-1, and AXL proteins and downregulation of Src protein [11]. Here, PRKCA is linked to urinary bladder cancer.